Apigenin Alleviates Resistance to Doxorubicin in Breast Cancer Cells by Acting on the JAK/STAT Signaling Pathway

The authors evaluated the effect of Apigenin on Doxorubicin (DOX) resistance in MCF-7 cells and a DOX-resistant MCF-7 cell line was developed by treating MCF-7 cells with increasing concentrations of DOX.